Ģ����ý

The foundation’s generosity will create the Pluta Professorship in Breast Care and enhance the Pluta Comprehensive Breast Care Program at Wilmot

The has committed $4 million to . The investment will establish the endowed Pluta Professorship in Breast Care to support ongoing faculty excellence. It will also name the at Wilmot, providing immediate funds to advance recruitment and retention initiatives and clinical trials around Wilmot’s developmental therapeutics efforts.

“We are incredibly grateful to the Pluta Cancer Foundation for these investments and for its longtime commitment to cancer patients, survivors, and the community,” says David Linehan, MD, CEO of the Ģ����ý Medical Center, dean of the School of Medicine and Dentistry, and senior vice president for health sciences. “The foundation’s generosity will enhance research opportunities, support innovative teaching initiatives, and attract leading experts in cancer care.

“The Pluta Cancer Foundation and Wilmot are singularly focused on helping those with a cancer diagnosis at all stages of their treatment, care, and recovery,” says Ron Pluta, chair of the Pluta Cancer Foundation board. “We’re proud to make this commitment, which is possible through the generosity of all our donors over the years. This truly aligns with our mission to support cancer patients and invest in the professional development of those on the frontlines of patient care.”

The Pluta legacy began in 1975 when the family named the Pluta Cancer Center at Genesee Hospital. When the hospital closed in 2001, the family worked to establish what would be New York’s first independent not-for-profit cancer center. In 2012, the Pluta Cancer Center joined the Ģ����ý’s Wilmot Cancer Institute, and the Pluta Cancer Foundation was established. Today, the Pluta Cancer Center at Wilmot is home to the Pluta Comprehensive Breast Care Program and the , which optimizes health, quality of life, and clinical outcomes.

“We extend our profound gratitude to the Pluta Cancer Foundation,” says Jonathan Friedberg, MD, director of the Wilmot Cancer Institute. “This expanded partnership provides critical support to Wilmot’s bold strategic plan as one of the elite cancer centers in the United States.”